ENTOURAGE HEALTH CORP (ENTG.CA) Fundamental Analysis & Valuation

TSX-V:ENTG • CA2938611001

Current stock price

0.005 CAD
0 (0%)
Last:

This ENTG.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ENTG.CA Profitability Analysis

1.1 Basic Checks

  • In the past year ENTG has reported negative net income.
  • In the past year ENTG has reported a negative cash flow from operations.
  • In the past 5 years ENTG always reported negative net income.
  • In the past 5 years ENTG always reported negative operating cash flow.
ENTG.CA Yearly Net Income VS EBIT VS OCF VS FCFENTG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -20M -40M -60M -80M -100M

1.2 Ratios

  • ENTG has a Return On Assets of -170.85%. This is amonst the worse of the industry: ENTG underperforms 88.89% of its industry peers.
Industry RankSector Rank
ROA -170.85%
ROE N/A
ROIC N/A
ROA(3y)-155.61%
ROA(5y)-104.81%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ENTG.CA Yearly ROA, ROE, ROICENTG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 -200 -300

1.3 Margins

  • ENTG's Gross Margin of 13.18% is on the low side compared to the rest of the industry. ENTG is outperformed by 72.22% of its industry peers.
  • In the last couple of years the Gross Margin of ENTG has remained more or less at the same level.
  • ENTG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 13.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y0.13%
ENTG.CA Yearly Profit, Operating, Gross MarginsENTG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. ENTG.CA Health Analysis

2.1 Basic Checks

  • ENTG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ENTG has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for ENTG is higher compared to a year ago.
ENTG.CA Yearly Shares OutstandingENTG.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
ENTG.CA Yearly Total Debt VS Total AssetsENTG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -30.71, we must say that ENTG is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -30.71, ENTG is doing worse than 91.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -30.71
ROIC/WACCN/A
WACC0.76%
ENTG.CA Yearly LT Debt VS Equity VS FCFENTG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M -100M

2.3 Liquidity

  • ENTG has a Current Ratio of 0.10. This is a bad value and indicates that ENTG is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ENTG has a worse Current ratio (0.10) than 94.44% of its industry peers.
  • A Quick Ratio of 0.04 indicates that ENTG may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.04, ENTG is not doing good in the industry: 94.44% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.1
Quick Ratio 0.04
ENTG.CA Yearly Current Assets VS Current LiabilitesENTG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ENTG.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 64.09% over the past year.
  • ENTG shows a small growth in Revenue. In the last year, the Revenue has grown by 5.08%.
  • ENTG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 38.62% yearly.
EPS 1Y (TTM)64.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.53%
Revenue 1Y (TTM)5.08%
Revenue growth 3Y11.42%
Revenue growth 5Y38.62%
Sales Q2Q%9.09%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ENTG.CA Yearly Revenue VS EstimatesENTG.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
ENTG.CA Yearly EPS VS EstimatesENTG.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 -0.05 -0.1 -0.15

More info and screens

Find the best growth stocksShow best growing peers

0

4. ENTG.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ENTG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ENTG.CA Price Earnings VS Forward Price EarningsENTG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ENTG.CA Per share dataENTG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ENTG.CA Dividend Analysis

5.1 Amount

  • No dividends for ENTG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

ENTG.CA Fundamentals: All Metrics, Ratios and Statistics

ENTOURAGE HEALTH CORP

TSX-V:ENTG (4/8/2025, 7:00:00 PM)

0.005

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-28
Earnings (Next)05-05
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.54%
Ins Owner ChangeN/A
Market Cap1.53M
Revenue(TTM)41.46M
Net Income(TTM)-42.16M
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.14
BVpS-0.56
TBVpS-0.56
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -170.85%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 13.18%
FCFM N/A
ROA(3y)-155.61%
ROA(5y)-104.81%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y0.13%
F-Score4
Asset Turnover1.68
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 100.24%
Cap/Sales 1.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.1
Quick Ratio 0.04
Altman-Z -30.71
F-Score4
WACC0.76%
ROIC/WACCN/A
Cap/Depr(3y)116.21%
Cap/Depr(5y)4125%
Cap/Sales(3y)2.76%
Cap/Sales(5y)56.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.53%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.08%
Revenue growth 3Y11.42%
Revenue growth 5Y38.62%
Sales Q2Q%9.09%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y43.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y81.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.85%
OCF growth 3YN/A
OCF growth 5YN/A

ENTOURAGE HEALTH CORP / ENTG.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ENTOURAGE HEALTH CORP (ENTG.CA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to ENTG.CA.


Can you provide the valuation status for ENTOURAGE HEALTH CORP?

ChartMill assigns a valuation rating of 0 / 10 to ENTOURAGE HEALTH CORP (ENTG.CA). This can be considered as Overvalued.


What is the profitability of ENTG stock?

ENTOURAGE HEALTH CORP (ENTG.CA) has a profitability rating of 0 / 10.


Can you provide the financial health for ENTG stock?

The financial health rating of ENTOURAGE HEALTH CORP (ENTG.CA) is 0 / 10.